TCT-357 Transcatheter Aortic Valve Replacement with a 34-mm Repositionable Self-Expanding Bioprosthesis
Tanvir Bajwa(Aurora Health Care), Jeffrey J. Popma(Cardiovascular Research Foundation), Mathew Williams(Mount Sinai Health System), Stanley Chetcuti(University of Michigan), G. Michael Deeb(University of Michigan), Hemal Gada(University of Pittsburgh Medical Center), Mubashir Mumtaz(University of Pittsburgh Medical Center), Daniel O’Hair(UPMC Health System)
Cited by 6
Related Papers
Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients
|New England Journal of Medicine|2011|6.4k
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
|New England Journal of Medicine|2016|5.1k
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
|New England Journal of Medicine|2019|4.8k
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients
|New England Journal of Medicine|2019|3.6k
Stenting versus Endarterectomy for Treatment of Carotid-Artery Stenosis
|New England Journal of Medicine|2010|3k